本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

32.50
-0.3300-1.01%
盘后32.500.00000.00%19:30 EDT
成交量:71.79万
成交额:2,314.93万
市值:34.86亿
市盈率:-19.94
高:32.77
开:32.56
低:31.70
收:32.83
52周最高:34.00
52周最低:10.77
股本:1.07亿
流通股本:6,084.98万
量比:0.73
换手率:1.18%
股息:- -
股息率:- -
每股收益(TTM):-1.6302
每股收益(LYR):-1.6302
净资产收益率:-34.19%
总资产收益率:-23.02%
市净率:6.68
市盈率(LYR):-19.94

数据加载中...

2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/22

重要事件披露

Form 8-K - Current report
2024/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report